Rx price watch report: price growth for brand name and specialty drugs more than offset price decrease for generic drugs

Rx price watch report: price growth for brand name and specialty drugs more than offset price decrease for generic drugs

Collection:
Health Policy and Services Research
Series Title(s):
Rx price watch
Author(s):
Schondelmeyer, Stephen W., author
Purvis, Leigh, author
Contributor(s):
AARP (Organization), issuing body.
Public Policy Institute (AARP (Organization)), issuing body.
Publication:
Washington, DC : AARP Public Policy Institute, September 2019
Language(s):
English
Format:
Text
Subject(s):
Drug Costs -- trends
Drugs, Generic -- economics
Prescription Drugs -- economics
United States
Genre(s):
Technical Report
Abstract:
In 2017, retail prices for a combined set of 754 widely used prescription drugs (brand name, generic, and specialty) increased by an average of 4.2 percent; in contrast, the general inflation rate was 2.1 percent over the same period. The average annual increase in retail prices for the AARP combined set of drug products exceeded corresponding rate general inflation every year from 2006 through 2017. These findings are attributable primarily to price growth among brand name and specialty drugs, which more than offset often substantial decreases generic drugs.
Copyright:
Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY-NC-ND license. (More information)
Extent:
1 online resource (1 PDF file (2 pages))
Illustrations:
Illustrations
NLM Unique ID:
101769470 (See catalog record)
Permanent Link:
http://resource.nlm.nih.gov/101769470